A Study of TQ-B3525 in Subjects With Relapse/Refractory Diffuse Large B-cell Lymphoma （DLBCL）
Clinical trial NCT04610970 · UNKNOWN
Trial details
- NCT number
- NCT04610970
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-20
- Primary completion
- 2022-03-31
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.